Breast cancer is a molecularly, biologically and clinically heterogeneous group of disorders. Understanding this diversity is essential to improving diagnosis and optimising treatment. Both genetic an
-The co-immunostaining of NUP98 and H3K27me3 in CD34+ cells treated with DMSO and EPZ6438 (0.5μM). H3K27me3 is stained with Alexa 594 secondary antibody. After EPZ6438 (0.5μM), we can see a significan
We first identified candidate VMRs, defined as regions of CpG-sites showing the highest variability across all methylation sites.To examine the factors that best explain the variance in methylation in
